injections tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Bests Semaglutide for Real-World

This medication, often administered in units rather than milligrams, requires familiarity with its varying concentrations to ensure accurate dosing

Some even claim that it can harm you

Mounjaro has been on the FDA's shortage list since the latter part of 2022, and Zepbound was added in April of 2024

How PlexusDx Makes Tirzepatide Accessible Without Insurance Insurance denials are among the most common barriers preventing Washington residents from accessing tirzepatidemany insurers classify weight loss medications as cosmetic rather than medical

Possible long-term risks include: Gallstones or gallbladder inflammation, especially with rapid weight loss Pancreatitis, which is inflammation of the pancreas Kidney stress or acute kidney injury linked with dehydration from vomiting or diarrhoea Severe constipation or worsening digestive symptoms Delayed stomach emptying or gastroparesis-like symptoms Possible worsening of diabetic retinopathy in some people with type 2 diabetes, especially if blood sugar improves very quickly Increased heart rate in some people Allergic reactions, such as swelling, rash, itching, or breathing difficulty Mood changes or suicidal thoughts, which need immediate medical attention Loss of lean muscle mass if weight loss happens without enough protein and strength training Facial volume loss due to rapid weight loss, sometimes called Ozempic face, although this can happen with rapid weight loss from any cause Some GLP-1 medicines carry a warning related to thyroid C-cell tumours seen in animal studies

Stay hydrated with small sips throughout the day rather than large gulps